We are a speciality chemical manufacturer who, through the imaginative and practical use of science, creates ingredients and technologies that improve people’s lives by enhancing everyday products.

Read more about Croda

Investor Centre

Financial Highlights - Six months ended 30 June 2015

Revenue

£565.6m
(2014: £537.4m)

Adjusted Operating Profit

£139.3m
(2014: £132.3m)

Interim Dividend per share

31.0p
(2014: 29.5p)

NPP sales as a % of Group sales

25.8%
(2014: 22.5%)

Croda’s Insights into “Bioavailability in the Skin” Shared at Metropolitan University of Mexico Event

June 2015: Croda recently presented a lecture on “Bioavailability in The Skin” to 120 attendees at the Metropolitan University of Mexico...read the full article

Croda appoints Head Of Investor Relations

Conleth Campbell has been formally appointed as Vice President Investor Relations and Corporate Finance for Croda International plc...read the full article